Red blood cell microparticles: clinical relevance

Olivier Rubin1, Giorgia Canellini, Julien Delobel

  • 1Service Régional Vaudois de Transfusion Sanguine, Epalinges, Switzerland.

Abstract

Insights

Erythrocyte-derived microparticles, released from red blood cells, are present in blood transfusions. Emerging evidence suggests these microparticles may contribute to transfusion complications.

Area of Science:

  • Hematology
  • Transfusion Medicine
  • Cellular Biology

Background:

  • Microparticles are small vesicles released from various cell types, including red blood cells.
  • These particles play roles in physiological processes like hemostasis.
  • Elevated microparticle levels are linked to pathological conditions.

Purpose of the Study:

  • To review recent data on erythrocyte-derived microparticles in transfusion medicine.
  • To explore the potential role of these microparticles in transfusion complications.

Main Methods:

  • Literature review of recent studies on erythrocyte-derived microparticles.
  • Analysis of data related to microparticle presence in red blood cell concentrates.

Main Results:

  • Erythrocyte-derived microparticles are found in stored red blood cell concentrates.
  • Their precise function is not fully understood and they are often considered storage lesions.

Conclusions:

  • Erythrocyte-derived microparticles are increasingly recognized as significant in transfusion medicine.
  • These microparticles may be implicated in adverse transfusion reactions.